Hyporesponsiveness to Darbepoetin Alfa in Patients With Heart Failure and Anemia in the RED-HF Study (Reduction of Events by Darbepoetin Alfa in Heart Failure): Clinical and Prognostic Associations.
Author | |
---|---|
Abstract |
:
A poor response to erythropoiesis-stimulating agents such as darbepoetin alfa has been associated with adverse outcomes in patients with diabetes mellitus, chronic kidney disease, and anemia; whether this is also true in heart failure is unclear. |
Year of Publication |
:
2018
|
Journal |
:
Circulation. Heart failure
|
Volume |
:
11
|
Issue |
:
2
|
Number of Pages |
:
e004431
|
ISSN Number |
:
1941-3289
|
URL |
:
http://circheartfailure.ahajournals.org/cgi/pmidlookup?view=long&pmid=29367268
|
DOI |
:
10.1161/CIRCHEARTFAILURE.117.004431
|
Short Title |
:
Circ Heart Fail
|
Download citation |